Publication | Closed Access
A double-blind crossover trial on the effect of cetylpyridinium chloride 0.05 per cent (Merocet) on plaque accumulation
34
Citations
0
References
1980
Year
Cetylpyridinium Chloride 0.05MedicineToxicologyPlaque AccumulationEnvironmental ToxicologyClinical ChemistryPharmacologyDouble-blind Crossover Trial
No additional data available for this publication yet. Check back later!